What is the main business of Magmax?

The main business activity of Magmax focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 7, 2014.

Where is the headquarters located?

The headquarters is located at: Żwirki I Wigury 16A, 02-092 Warszawa.

Who is on the management board?

The management board consists of: Grzegorz Bajtała (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $4,200,912, representing an increase of 10.9% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $33,580.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,837,502 in 2024, representing 69% of all operating expenses.

MagmaxS.A.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-11-07

Share capital

100 000,00 PLN

Registered address

Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland

Website

magmaxsa.pl

Electronic delivery address

AE:PL-56879-58529-EVIRT-12

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.57mMedianUSD 1.75mAverageUSD 5.00m

Net profit

This companyUSD 95.78kMedianUSD 17.49kAverageUSD 85.24k

Operating costs

This companyUSD 4.43mMedianUSD 1.72mAverageUSD 4.85m

Assets

This companyUSD 881.77kMedianUSD 495.38kAverageUSD 1.71m

Industry

Bank accounts

Registered as a VAT taxpayer on 2015-04-17. Active

Erste Bank Polska
07 1090 1056 0000 0001 3647 7949
Erste Bank Polska
14 1090 1056 0000 0001 3647 8017
Erste Bank Polska
93 1090 1056 0000 0001 5312 4123

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Buildings and premises	PLN 75,880PLN 75,880

MSiG notices

Publication date	Event
Aug 20, 2015	Shareholders' meeting convened
Jun 25, 2015	Shareholders' meeting convened

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,815$4,815	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,983$4,983	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,554$4,554	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Magmax has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Inne usługi realizowane w aptekach	śląskie	2	USD 0.00

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Grzegorz Bajtała – President of the Management Board

Manner of representation

In the case of a multi-member management board, the action of two members of the management board jointly, or of a member of the management board jointly with a commercial proxy, is required to make declarations of will on behalf of the company. In the case of a one-person management board, the company is represented by the sole member of the management board independently.

Supervisory board

Bożena Kubica – Supervisory Board Member

Joanna Chałupa – Supervisory Board Member

Zbigniew Chojnowski – Supervisory Board Member

Ownership

Owner
Megafarm sp. z o.o.

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Cosmedicasp. z o.o.	$49,355,260.75	cosmedica.pl
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
Adpharmasp. z o.o.	$4,026,799.19	adamed.com
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com

Change history

Date	Event
2023-10-18	Address change (Ul. Fabryczna 45, 43-100, Tychy → Żwirki I Wigury 16a/Biuro 315, 02-092, Warszawa)
2023-10-18	PKD change (Removed: 58.14.Z; Added: 47.29.Z)
2019-01-16	Address change (Kilińskiego 228, 93-124, Łódź → Ul. Fabryczna 45, 43-100, Tychy)
2018-10-17	PKD change (Removed: 46.45.Z; Added: 52.10.B)
2016-01-13	PKD change (Removed: 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32.12.Z, 32.13.Z, 32.2, 32.3, 32.4, 32.5, 32.9, 33, 35, 36, 37, 38, 39, 41, 42, 43, 45, 46, 47, 49, 50, 51, 52, 53.20.Z, 55, 56, 58, 59, 60, 61, 62, 63, 64.19.Z, 64.20.Z, 64.9, 66, 68, 69.10.Z, 69.20.Z, 70, 71, 72, 73, 74, 75, 77, 78, 79, 80, 81, 82, 85, 86, 87, 88, 90, 91, 92, 93, 95, 96; Added: 21.20.Z, 46.45.Z, 47.73.Z, 47.74.Z, 47.75.Z, 58.14.Z, 78.10.Z, 78.30.Z, 86.90.E, 96.09.Z)

FAQ

Last updated: 2026-07-09